Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin

Journal of Medicinal Food

Volumn 12, Issue 1, 2009, Pages 8-14

  Lee, Yeo Myeong ^a   Lim, Do Young ^a   Choi, Hyun Ju ^a   Jung, Jae In ^a   Chung, Won Yoon ^b   Park, Jung Han Yoon ^a  

^a Hallym University   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

Author keywords

Cyclin; Cyclin dependent kinase; Cyclin dependent kinase inhibitor; DU145 cells; MatLyLu cells

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 2 INHIBITOR; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; ISOLIQUIRITIGENIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; CHALCONES; CYCLIN-DEPENDENT KINASES; CYCLINS; DIET; ENZYME INHIBITORS; FABACEAE; GLYCYRRHIZA; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; RATS; SHALLOTS;

ALLIUM ASCALONICUM; GLYCYRRHIZA; RATTUS;

EID: 64949183401     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0039     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Feldman BJ, Feldman D: The development of androgen-inde-pendent prostate cancer. Nat Rev Cancer 2001;1:34-45.
3. Heinlein CA, Chang C: Androgen receptor in prostate cancer. Endocr Rev 2004;25:276-308.
4. Potter JD, Steinmetz K: Vegetables, fruit and phytoestrogens as preventive agents. In: IARC Scientific Publication Number 139: Principles of Chemoprevention (Stewart BW, McGregor D, Kleihues P, eds.). IARC Press, Lyon, France, 1996, pp. 61-90.
5. Whittemore AS, Kolonel LN, Wu AH, et al.: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652-661.
6. Clinton SK, Giovannucci E: Diet, nutrition, and prostate cancer. Annu Rev Nutr 1998;18:413-440.
7. Birt DF, Hendrich S, Wang W: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001;90:157-177.
8. Yamamoto S, Aizu E, Jiang H, et al.: The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis 1991;12:317-323.
9. Takahashi T, Takasuka N, Iigo M, et al.: Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 2004;95:448-453.
10. Baba M, Asano R, Takigami I, et al.: Studies on cancer chemoprevention by traditional folk medicines. XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull 2002;25:247-250.
11. Yamazaki S, Morita T, Endo H, et al.: Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 2002;183:23-30.
12. Ii T, Satomi Y, Katoh D, et al.: Induction of cell cycle arrest and p21(CIP1/WAF1) expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 2004;207:27-35.
13. Hsu YL, Kuo PL, Chiang LC, Lin CC: Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells. Clin Exp Pharmacol Physiol 2004; 31:414-418.
14. Hsu YL, Kuo PL, Lin CC: Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells. Life Sci 2005;77:279-292.
15. Maggiolini M, Statti G, Vivacqua A, et al.: Estrogenic and an-tiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 2002;82:315-322.
16. Ma J, Fu NY, Pang DB, Wu WY, Xu AL: Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 2001;67:754-757.
17. Jung JI, Lim SS, Choi HJ, et al.: Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 2006;17:689-696.
18. Kanazawa M, Satomi Y, Mizutani Y, et al.: Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 2003;43:580-586.
19. Meeran SM, Katiyar SK: Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 2008;13: 2191-2202.
20. Sherr CJ: The Pezcoller Lecture: cancer cell cycles revisited. Cancer Res 2000;60:3689-3695.
21. Sherr CJ, McCormick F: The RB and p53 pathways in cancer. Cancer Cell 2002;2:103-112.
22. Stark GR, Taylor WR: Control of the G2/M transition. Mol Biotechnol 2006;32:227-248.
23. Golan A, Yudkovsky Y, Hershko A: The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J Biol Chem 2002;277:15552-15557.
24. Sullivan M, Morgan DO: Finishing mitosis, one step at a time. Nat Rev 2007;8:894-903.
25. Jung JI, Chung E, Seon MR, et al.: Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors 2006;28:159-168.
26. Lim DY, Jeong Y, Tyner AL, Park JH: Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol 2007;292:G66-G75.
27. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
28. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellon EA: Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 2007;28:282-293.
29. Sherr CJ: Cancer cell cycles. Science 1996;274:1672-1677.
30. Polyak K: The p27Kip1 tumor suppressor gene: still a suspect or proven guilty? Cancer Cell 2006;10:352-354.
31. Lee MH, Yang HY: Negative regulators of cyclin-dependent ki-nases and their roles in cancers. Cell Mol Life Sci 2001;58:1907-1922.
32. kip1 functional regulation in human cancer: a potential target for therapeutic designs. Curr Med Chem 2005;12:1589-1605.
33. McGowan CH, Russell P: Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J 1993;12:75-85.
34. Watanabe N, Broome M, Hunter T: Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J 1995;14:1878-1891.
35. Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995;80:225-236.
36. Donzelli M, Draetta GF: Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 2003;4:671-677.
37. Galaktionov K, Jessus C, Beach D: Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev 1995;9:1046-1058.
38. Glotzer M, Murray AW, Kirschner MW: Cyclin is degraded by the ubiquitin pathway. Nature 1991;349:132-138.
39. Hershko A: Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 1997;9:788-799.
40. Parry DH, O'Farrell PH: The schedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis. Curr Biol 2001;11:671-683.
41. Vorlaufer E, Peters JM: Regulation of the cyclin B degradation system by an inhibitor of mitotic proteolysis. Mol Biol Cell 1998; 9:1817-1831.
42. Lin H, Liu XY, Subramanian B, Nakeff A, Valeriote F, Chen BD: Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination. Int J Cancer 2002;97:121-128.
43. Chen S, Gao J, Halicka HD, Traganos F, Darzynkiewicz Z: Downregulation of androgen-receptor and PSA by phytochemicals. Int J Oncol 2008;32:405-411.
44. Rokhlin OW, Bishop GA, Hostager BS, et al.: Fas-mediated apop-tosis in human prostatic carcinoma cell lines. Cancer Res 1997; 57:1758-1768.
45. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990;247:712-715.
46. Kuwajima H, Taneda Y, Chen W, et al.: Variation of chemical constituents in processed licorice roots: quantitative determination of saponin and flavonoid constituents in bark removed and roasted licorice roots. Yakugaku Zasshi 1999;119:945-955.